CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers
Peter A. Fasching(Universitätsklinikum Erlangen), Marina Bermisheva(Russian Academy of Sciences), Federico Canzian(German Cancer Research Center), Minouk J. Schoemaker(Institute of Cancer Research), Nichola Johnson(Institute of Cancer Research), Volker Arndt(German Cancer Research Center), Angela Cox, Hiltrud Brauch(German Cancer Research Center), A. Heather Eliassen(Brigham and Women's Hospital), Natalia Bogdanova(Medizinische Hochschule Hannover), Fergus J. Couch(Mayo Clinic), Jose E. Castelao(Servicio Gallego de Salud), Simon S. Cross(University of Sheffield), Thilo Dörk(Hannover Re (Germany)), Michael E. Jones(Institute of Cancer Research), Joe Dennis(University of Cambridge), Christoph Engel(University Hospital Leipzig), Anna Morra(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Caroline Baynes(University of Cambridge), Kamila Czene(Karolinska Institutet), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Matthias W. Beckmann(Universitätsklinikum Erlangen), Thomas U. Ahearn(Harvard University), Irene L. Andrulis(University of Toronto), Javier Benı́tez(Spanish National Cancer Research Centre), Sarah Maguire(Breast Cancer Now), Christine L. Clarke(Memorial University of Newfoundland), Carl Blomqvist(University of Helsinki), Clare Gilham(London School of Hygiene & Tropical Medicine), Daniele Campa(University of Pisa), Stig E. Bojesen(University of Copenhagen), Katarzyna Tomczyk(Institute of Cancer Research), Hermann Brenner(Universidad de Granada), Hoda Anton‐Culver(University of California, Irvine), Bram Boeckx(VIB-KU Leuven Center for Cancer Biology), Don Conroy(University of Cambridge), Laura E. Beane Freeman(National Cancer Institute), D. Gareth Evans(Manchester Academic Health Science Centre), Pooja Middha(German Cancer Research Center), Kristan J. Aronson(Queen's University), Stephen J. Chanock(National Cancer Institute), Qin Wang(University of Cambridge), Barbara Burwinkel(German Cancer Research Center), Natalia Antonenkova(N.N. Alexandrov National Cancer Centre), Annelie Augustinsson(Lund University), Manjeet K. Bolla(University of Cambridge)
Cited by 9
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k